Mylan Confirms First-to-File Patent Challenge Relating to FROVA Tablets - Drugs.com MedNews
Links shared publicly online about this topic.
- 66total visits
Mylan Confirms First-to-File Patent Challenge Relating to FROVA Tablets - Drugs.com MedNews
Expects to qualify for 180 days of marketing exclusivity Mylan Inc. (Nasdaq MYL) today confirmed that the company and its subsidiary Mylan Pharmaceuticals Inc.
View full resource at drugs.com
Tags: Migraine Medication, Triptans, Drug, Pharma, Frova
Most Recently Shared on August 17, 2011 at 2:14 pm By:
Mylan Confirms First-to-File Patent Challenge Relating to FROVA Tablets: Expects to qualify for 180 days o... http://t.co/MmjpdFX #drug
Advertisement
